Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study
Year: 2019
Type: conference-abstract
Source: Blood
Institutions: Sun Yat-sen University Cancer Center, Samsung Medical Center, National Taiwan University Hospital, Seoul National University Hospital, Asan Medical Center, The Catholic University of Korea Seoul St. Mary's Hospital, National Cancer Center, China Medical University Hospital, National Cancer Centre Singapore, Peking University Cancer Hospital, Severance Hospital, Queen Mary Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2985651908